Rachel Haurwitz
Rachel Haurwitz | |
|---|---|
Haurwitz in 2019 | |
| Born | Rachel Elizabeth Haurwitz May 20, 1985 Austin, Texas, U.S. |
| Alma mater |
|
| Scientific career | |
| Fields | Biochemistry |
| Institutions | Caribou Biosciences |
| Thesis | The CRISPR endoribonuclease Csy4 utilizes unusual sequence- and structure-specific mechanisms to recognize and process crRNAs (2012) |
| Doctoral advisor | Jennifer Doudna |
Rachel Elizabeth Haurwitz (born May 20, 1985) is an American biochemist and structural biologist. She is the co-founder, chief executive officer, and president of Caribou Biosciences, a genome editing company.